Search

Author/Creator Hilder, Brandi W.

1. A Phase 1 and 2 study of Filanesib alone and in combination with low‐dose dexamethasone in relapsed/refractory multiple myeloma. Issue 23 (17th August 2017)

Authors:
Shah, Jatin J.; Kaufman, Jonathan L.; Zonder, Jeffrey A.; Cohen, Adam D.; Bensinger, William I.; Hilder, Brandi W.; Rush, Selena A.; Walker, Duncan H.; Tunquist, Brian J.; Litwiler, Kevin S.; Ptaszynski, Mieke; Orlowski, Robert Z.; Lonial, Sagar
Journal:
Cancer
Issue:
Volume 123:Issue 23(2017)
Page Start:
4617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 1 dose‐escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma. Issue 21 (19th July 2016)

Authors:
Chari, Ajai; Htut, Myo; Zonder, Jeffrey A.; Fay, Joseph W.; Jakubowiak, Andrzej J.; Levy, Joan B.; Lau, Kenneth; Burt, Steven M.; Tunquist, Brian J.; Hilder, Brandi W.; Rush, Selena A.; Walker, Duncan H.; Ptaszynski, Mieke; Kaufman, Jonathan L.
Journal:
Cancer
Issue:
Volume 122:Issue 21(2016)
Page Start:
3327
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search